Idea or Concept – Page 20

Eli Lilly’s Kisunla Shows Reduced Brain Swelling with Modified Dosing Regimen in Alzheimer’s Patients

11 months ago talkbio0Tagged Alzheimer 's disease, ARIA-E, Cerebral Edema, Changing, dosing, Eli, Eli Lilly, Kisunla, Risk, Treatment Protocols

Eli Lilly, Kisunla, Alzheimer’s disease, brain swelling, modified dosing regimen, ARIA-E risk reduction

Iambic Therapeutics Enhances AI Suite with “Enchant” for Predictive Preclinical Drug Development

11 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, clinical success, Drug Discovery, Enchant, Iambic, preclinical predictive powers, Prediction

Iambic Therapeutics, AI, Enchant, preclinical predictive powers, drug discovery, clinical success prediction

Tyra Biosciences Unveils Early Data for FGFR3 Inhibitor, TYRA-300, in Challenge to J&J’s Balversa

11 months ago talkbio0Tagged Balversa, Carcinoma, Transitional Cell, concerns, Effectiveness, FGFR3 protein, human, Inhibitor, J&J, Malignant neoplasm of urinary bladder, Safety, Tyra Biosciences, TYRA-300

Tyra Biosciences, TYRA-300, Balversa, J&J, bladder cancer, urothelial carcinoma, FGFR3 inhibitor, safety concerns, efficacy data

CDC Recommends Pneumococcal Vaccination for Adults 50 Years and Older

11 months ago talkbio0Tagged Administration of vaccine product containing only Streptococcus pneumoniae antigen (procedure), Adult, Centers for Disease Control and Prevention (U.S.), older, pneumococcal disease prevention, Recommendation, respiratory season

Pneumococcal vaccination, CDC recommendations, adults 50 and older, pneumococcal disease prevention, winter respiratory season.

HLTH24: Atropos Health Introduces AI-Powered Chat Co-Pilot for Rapid Real-World Evidence Generation

11 months ago talkbio0Tagged Atropos, Chat-Based AI, ChatRWD, Evidence, Generative AI, GENEVA, Health, Health care facility, HLTH24, Oral region, Pilot, Real-world

Atropos Health, HLTH24, Chat-Based AI Co-Pilot, Real-World Evidence, Generative AI, Healthcare Evidence Generation, GENEVA OS, ChatRWD

Starboard Value Criticizes Pfizer Leadership Over Underperforming R&D and Overpriced Acquisitions

11 months ago talkbio0Tagged Accountability, activist investor, Corporate, Drug Industry, Overpaid M&A Deals, Pfizer, R&D, Starboard Value

Pfizer Inc., Starboard Value, Activist Investor, Pharmaceutical Industry, R&D Underperformance, Overpaid M&A Deals, Corporate Accountability

Starboard Value Targets Kenvue for Revitalization Following $1B Stake in Pfizer

11 months ago talkbio0Tagged activist investor, Consumer, Health, Johnson & Johnson, Kenvue, Pfizer, Pfizer/, Starboard Value

Starboard Value, Kenvue, Johnson & Johnson, Pfizer, activist investor, consumer health, pharmaceuticals

Vertex’s Non-Opioid Pain Drug Suzetrigine Nears FDA Approval: A Breakthrough in Acute Pain Management

11 months ago talkbio0Tagged acute pain management, addiction, Approved, Feeling relief, non-opioid pain drug, Opioid Epidemic, Pain, Risk, signal inhibitor, Suzetrigine, United States Food and Drug Administration

Suzetrigine, Non-opioid pain drug, Acute pain management, FDA approval, Vertex Pharmaceuticals, NaV1.8 pain signal inhibitor, Opioid epidemic, Pain relief without addiction risk

Noom and Waltz Health Collaborate on Affordable GLP-1 Weight Loss Program

11 months ago talkbio0Tagged Glucagon-Like Peptide 1, Health, Medication Management, Noom, Obesity

Noom, Waltz Health, GLP-1, weight loss, affordable, medication management, obesity treatment

Wave Life Sciences Sees Historic Stock Surge Following Breakthrough in RNA Editing Therapy

11 months ago talkbio0Tagged Clinical Trials, Hereditary Diseases, liver complications, Lung, RNA Editing, surge, Wave Life Sciences, WVE-006

Wave Life Sciences, RNA editing, genetic condition, lung and liver complications, WVE-006, biotech, stock surge, clinical trial data